Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- Directory of Abstract Indexing for Journals
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 58 | 59 | 65 | 23 | 13 | 36 | 34 | 49 | 63 | 101 | 62 | 44 | 26 |
Research, Review articles and Editorials |
2 | 4 | 1 | 2 | 12 | 12 | 29 | 28 | 44 | 56 | 80 | 48 | 12 | 19 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 54 | 58 | 63 | 11 | 1 | 7 | 6 | 5 | 7 | 21 | 14 | 32 | 6 |
Conference proceedings |
0 | 40 | 12 | 37 | 0 | 0 | 145 | 138 | 95 | 63 | 154 | 72 | 54 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
522 | 678 | 761 | 838 | 697 | 626 | 613 | 599 | 538 | 478 | 262 | 142 | 31 | 69 |
| Journal total citations count | 6793 |
| Journal impact factor | 1.64 |
| Journal 5 years impact factor | 1.70 |
| Journal cite score | 11.56 |
| Journal h-index | 33 |
Important citations
Sutton MT, Fletcher D, Episalla N, Auster L, Kaur S, Gwin MC, Folz M, Velasquez D, Roy V, van Heeckeren R, Lennon DP. Mesenchymal stem cell soluble mediators and cystic fibrosis. Journal of stem cell research & therapy. 2017 Aug;7(9).
Sutton MT, Fletcher D, Episalla N, Auster L, Kaur S, Gwin MC, Folz M, Velasquez D, Roy V, van Heeckeren R, Lennon DP. Mesenchymal stem cell soluble mediators and cystic fibrosis. Journal of stem cell research & therapy. 2017 Aug;7(9).
Sutton MT, Fletcher D, Episalla N, Auster L, Kaur S, Gwin MC, Folz M, Velasquez D, Roy V, van Heeckeren R, Lennon DP. Mesenchymal stem cell soluble mediators and cystic fibrosis. Journal of stem cell research & therapy. 2017 Aug;7(9).
Raghavan PR. Metadichol® and CD34 Expression in Umbilical Cord Cells. J Stem Cell Res Ther. 2018;8(409):2.
Raghavan PR. Metadichol® and CD34 Expression in Umbilical Cord Cells. J Stem Cell Res Ther. 2018;8(409):2.
Damiani G, Berti E, Pigatto PD, Franchi C, Asa’ad F. Benchmarking Stem cells and transplantation in psoriasis. Journal of Stem Cell Research and Therapy. 2018;8:1000416.
Raghavan PR. Umbilical Cord Cells Treatment with Metadichol® IRS Proteins and GLUT4 Expression and Implications for diabetes. Stem Cell Res Ther. 2018;8(429):2.
Skurikhin EG, Pershina OV, Ermakova NN, Ermolaeva LA, Krupin VA. Polytherapy with Reserpine and Glucagon-like Peptide-1 (GLP-1) Improves the Symptoms in Streptozotocin-Induced Type-1 Diabetic Mice by Reducing Inflammation and Inducting Beta Cell Regeneration. Stem Cell Res Ther. 2018;8(434):2.
Lander EB, Berman MH. Autologous Stromal Vascular Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction. Stem Cell Res Ther. 2018;8(438):2.
Wu B, Chen D, Hu S. Corneal Stromal Remodelling Using Stem Cells-Advances and Potential Application: A Literature Review. J Stem Cell Res Ther. 2019;9(450):2.
Ghosh D, Mehta N, Patil A, Sengupta J (2016) Ethical issues in biomedical use of human embryonic stem cells (hESCs). Journal of Reproductive Health and Medicine.
Parsons XH (2016) inventor; San Diego Regenerative Medicine Institute, Xcelthera Inc, assignee. Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells. United States patent US.
Parsons XH. You should pass Article id number.
Sommese L, Zullo A, Schiano C, Mancini FP, Napoli C (2017) Possible Muscle Repair in the Human Cardiovascular System. Stem Cell Reviews and Reports 5: 1-22.
Parsons XH (2016) Journal of Regenerative Therapeutics.1: 1-8.
Ibrahim AY, Mehdi Q, Abbas AO, Alashkar A, Haider KH (2016) Induced Pluripotent Stem Cells: Next Generation Cells for Tissue Regeneration. Journal of Biomedical Science and Engineering 9: 226.
Parsons XH (2014) inventor; San Diego Regenerative Medicine Institute, assignee. Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells. United States patent US.
Offen N, Flemming J, Kamawal H, Ahmad R, Wolber W, et al. (2013) Effects of Erythropoietin in Murine-Induced Pluripotent Cell-Derived Panneural Progenitor Cells. Molecular Medicine 19: 399.
Parsons XH (2016) Human pluripotent stem cell-based PluriXcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. J Regen Ther 1: 1-8.
ABIDIN SZ, Abbaspourbabaei M, Ntimi CM, SIEW WH, Pike-See CH, et al. (2014) MiR-3099 is overexpressed in differentiating 46c mouse embryonic stem cells upon neural induction. The Malaysian journal of medical sciences: MJMS 21: 27.